WE GENE TECHNOLOGIES, INC.
Taiwan新北市中和區建一路166號18樓4 products representedApr 11, 2006 – Oct 26, 2016
VerifiedTFDA · Taiwan Food and Drug Administration registry
4
Products represented
3
Manufacturers
3
Active products
Oct 2016
Latest registration
Company details
- Address
- 新北市中和區建一路166號18樓
- Authorization Code
- 12645131.0
Regulatory footprint
Search WE GENE TECHNOLOGIES, INC. across other regulatory registries
Recent registrations
Latest 5 products represented by this organization
Most popular products
Products with most registrations
Represented manufacturers
Manufacturers whose products are represented by this organization
Recent represented products
Most recent products (showing top 20)
"Weijin" patch heart rate variability analyzer
Registered: Oct 26, 2016 • Expires: Oct 26, 2026
- Risk Class
- Class 2
- Manufacturer
- LEADTEK RESEARCH, INC.
"Weijin" simple ECG recorder
Registered: Feb 11, 2015 • Expires: Feb 11, 2025
- Risk Class
- Class 2
- Manufacturer
- LEADTEK RESEARCH, INC.
"Madebokang" electronic blood pressure monitor
Registered: Sep 04, 2013 • Expires: Sep 04, 2018
Cancelled
- Risk Class
- Class 2
- Manufacturer
- ONBO ELECTRONIC (SHENZHEN) CO. LTD
"Weijin Gene Technology" heart rhythm variation analyzer
Registered: Apr 11, 2006 • Expires: Apr 11, 2026
- Risk Class
- Class 2
- Manufacturer
- Weijin Gene Technology Co., Ltd.;; Leadtek Technology Co., Ltd
About this profile
Explore comprehensive authorized representative profile for WE GENE TECHNOLOGIES, INC. through Pure Global AI's free Taiwan medical device database. This authorized representative handles 4 product registrations across 3 manufacturers and 4 unique product types. Their regulatory history spans from Apr 11, 2006 to Oct 26, 2016.
This page provides detailed insights including 4 recent product registrations, 4 most popular products with "Weijin" patch heart rate variability analyzer having 1 registrations, and 3 represented manufacturers including LEADTEK RESEARCH, INC.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.